Assignee
VAXON BIOTECH
FR·1 granted patent·8 pending applications·4 citations·filing 2005–2020
Top patents by PatentIndex Score
9 records- 0165US7973128B2Immunogenic polypeptide composed of tumor antigen-derived optimized cryptic peptides, and uses thereofVAXON BIOTECH·Filed 2005·Granted Jul 5, 2011·4 cites·21 claims
- 0256US2017000866A1Method for emulsifying a triepitope peptide with montanide and kits for performing the sameVAXON BIOTECH·Filed 2014·Application pending·0 cites
- 0353US2019151427A1Method for Emulsifying a Triepitope Peptide with Montanide and Kits for Performing the SameVAXON BIOTECH·Filed 2019·Application pending·0 cites
- 0452US2014178421A1Use of Native Peptides and Their Optimized Derivatives For VaccinationVAXON BIOTECH·Filed 2013·Application pending·0 cites
- 0546US2013266598A1Identification, Optimization And Use Of Cryptic HLA-B7 Epitopes For ImmunotherapyVAXON BIOTECH·Filed 2013·Application pending·0 cites
- 0643US2022249642A1Combination of Markers for Predicting the Response to Vx-001VAXON BIOTECH·Filed 2020·Application pending·0 cites
- 0743US2017202936A1Identification, Optimization And Use Of Cryptic HLA-B7 Epitopes For ImmunotherapyVAXON BIOTECH·Filed 2017·Application pending·0 cites
- 0840US2020079819A1Use of a Vaccine Targeting a Cryptic Tert Epitope, for Treating Lung Cancer in a HLA-A*0201-Positive Never-Smoker or Light-Former Smoker PatientVAXON BIOTECH·Filed 2018·Application pending·0 cites
- 0925US2017157228A1Immunogenic Polypeptide Composed of HLA-B7 Restricted Tumor Antigen-Derived Optimized Cryptic Peptides, and Uses ThereofVAXON BIOTECH·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when VAXON BIOTECH files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →